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Abstract 
Introduction: Extraperitoneal, abdominal paragangliomas most commonly originate from the sympathetic nervous system. Typical 
features include catecholamine overproduction and the potential for malignancy. Lesions are usually located paravertebrally, but when 
growing in a more expansive manner they may also appear between the inferior vena cava and aorta. In the authors’ opinion this site 
excludes laparoscopic tumourectomy.
Material and methods: Twenty-eight patients were selected for surgical management of abdominal paragangliomas in the past eight 
years at our endocrine surgical centre. This group consisted of 21 (75%) women and seven (25%) men, aged 14 to 84 years (mean 47.9). In 
13 (46.4%) cases paroxysmal hypertension was observed. Type 2 diabetes was noted in another 10 (35.7%) patients, and Takotsubo acute 
coronary syndrome in two (7.1%). Patients were preoperatively qualified for either open surgery or laparoscopic tumourectomy based 
on visualisation and location of the tumours in imaging studies. 
Results: All patients were successfully operated. Eleven (39.3%) patients qualified for laparoscopy, while the remaining 17 (60.7%) were 
treated with an open surgical approach due to difficult access to the lesion. The mean operative time was 130 minutes for laparoscopy 
and 120 minutes for laparotomy (p = 0.2). There were no local or general complications after either type of procedure. 
Conclusions: The use of laparoscopic access is practically excluded in the treatment of paragangliomas located between the inferior vena 
cava and aorta, especially at the level of the renal vessels and extending superiorly to the diaphragm. (Endokrynol Pol 2019; 70 (6): 469–472)
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Introduction
Paragangliomas may arise in practically all locations in 
the human body in which ganglion or argyrophilic tis-
sue are present. In the majority of cases, they surround 
tissues of the central nervous system. The frequency of 
appearance in abdominal and pelvic areas is estimated 
to be approximately 21%. The exact location of paragan-
glioma influences its natural history, symptomatology, 
hormonal overactivity, and potential for malignancy. 
Abdominal paragangliomas arise from sympathetic 
ganglia and often have a tendency towards hormonal 
overproduction and malignancy, in comparison to other 
locations. The main symptoms are an abnormal mass 
in the abdominal cavity, hypertension, and abdominal 
pain [1]. In 25% of cases they are a part of multiple en-
docrine syndromes and express germinal mutations in 
the following genes: RET, VHL, SDHB, and SDHD [2].
Material and methods
Over the past eight years there were 440 patients operated due 
to adrenal disease in our clinic, of whom 28 (6.4%) were due to 
abdominally located paragangliomas. This group consisted of 21 
(75%) women and seven (25%) men, aged 14–82 years (mean 47.9). 
These patients were analysed according to clinical symptoms, 
tumour location, method of surgical treatment, histopathological 
tissue analysis, and other criteria. 
Symptomatology and diagnostics
Thirteen of 28 (46.4%) patients underwent initial diagnostics due 
to hypertension, while the remaining 15 (53.6%) remained asymp-
tomatic. In these latter cases, the presence of paraganglioma was 
confirmed incidentally (incidentaloma) during imaging studies 
performed for other indications. Hormonal overproduction defined 
by the presence of catecholamines in plasma was discovered in 
seven (25%) patients. Diagnosis was confirmed based on increased 
levels of metanephrine in 24-hour urine collection in all these cases, 
as well as two additional cases out of nine (32.1%). In 10 (35.7%) 
patients Takotsubo-like acute coronary syndrome had previously 
been reported. All endocrinological laboratory diagnostics were car-
ried out in the internal medicine and endocrinology departments. 
Based on imaging studies, it seems that ultrasound (US) is of key 
importance as a screening test. While analysing the diagnostic 
course of particular patients from the study group, it was discov-
ered that US was performed two to five times in each patient in 
order to assess tumour growth dynamics. Computed tomography 
(CT) was performed in all cases to estimate the topography of the 
tumour and its relation to adjacent structures (Fig. 1, 2). In several 
cases, confirmatory imaging was by magnetic resonance. I-MIGB 
and FDG-PET were also conducted in a few clinical scenarios, 
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per day. This treatment was introduced around two to four weeks 
before scheduled surgery. In the remaining seven (25%) patients, 
alpha blockers were not used.
After pharmacological preoperative treatment and exact localisation 
and analysis of the lesions, all patients were operated. Precise analy-
sis of location determined qualification for laparoscopic procedure 
in 11 (39.3%) patients. The remaining 17 (60.7%) were prepared for 
laparotomy. Indications for laparoscopy included: close proximity 
to adrenal glands, renal vessels bilaterally or paravertebrally below 
inferior vena cava on the right. 
Results
Lateral transperitoneal laparoscopic approach was 
performed in 11 patients, using four ports. Two of 
these patients required conversion to open surgery 
due to difficult tumour location. Paragangliomas were 
located proximal to both left and right adrenal glands 
in six patients, usually between the adrenal gland and 
especially in those patients with multiple lesions, or when tumour 
location was ambiguous. 
Location
The present study focused only on abdominal paragangliomas 
(subdiaphragmatic location). The tumour spread based on our 
material is presented in Table I.
In cases involving tumours of the organ of Zuckerkandl, three 
patients had tumours on the anterior aspect of the aorta found in 
imaging studies (three tumours in all cases). 
Tumours located between the inferior vena cava and aorta, especially 
at levels beginning from the aortic bifurcation and extending to the 
diaphragmatic crura, remain challenging from a surgical point of view. 
The majority of these cases excluded laparoscopic tumourectomy. The 
most difficult sites in particular involve tumours located retropancreati-
cally, as well as those superior and adjacent to the diaphragmatic crura.
Lesions located below the right renal vessels and inferior vena cava 
allow for laparoscopic tumourectomy, which is usually limited 
due to the proximity to the left adrenal gland. In order to remove 
a paraganglioma, it is often necessary to excise it en bloc with the 
right adrenal gland, due to surgical inability to precisely identify 
the border between the adrenal gland and paraganglioma.
It is impossible to separate paravertebrally located paragangliomas 
in most cases where the paraganglioma is in close relation with 
the left adrenal gland (Fig. 3). There are some situations, in which 
a different surgical approach or even conversion to open surgical 
technique is unavoidable. 
Treatment
Due to high risk of hormonal hyperactivity of the tumour, 21 (75%) 
patients were treated with alpha-blockers at a total dose of 6–12 mg 
Table I. The tumour spread based on authors’ material
Location No. %
Organ of Zuckerkandl 6 21.4
Between IVC and aorta 7 25.1
Below renal vessels 5 17.8
Below IVC 4 14.3
In the proximity of adrenals 6 21.4
Overall 28 100.0
Figure 1. Patient P.J., aged 76 years. Paraganglioma located 
between inferior vena cava and aorta, below pancreas and splenic 
artery, in computed tomography
Figure 2. Patient M.E., aged 61 years. Paraganglioma adjacent 
to celiac artery, in magnetic resonance imaging
Figure 3. Patient L.E. aged 73 years. Paraganglioma specimen 
excised together with adrenal gland. Paraganglioma visible in the 
foreground, with adjacent normal adrenal gland superiorly
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vertebral column, or below the lower pole of the adrenal 
gland. Adrenalectomy was performed when separa-
tion of the adrenal gland from the paraganglioma was 
impossible. The mean operating time was 130 minutes 
(range 75–210 minutes).
The remaining 17 patients qualified for open sur-
gery. Depending on tumour location, several different 
access points were used: midline incision in six cases, 
bilateral paramedian incision in six cases, and Kocher’s 
incision and lumbotomy in the remaining five cases. In 
those cases, the mean operating time was 120 minutes 
(range 75–150 minutes). 
Blood pressure spiked to values over 200/100 mm Hg 
in 13 cases, regardless of surgical method. This neces-
sitated pausing the procedure and administering 
additional hypotensive agents until blood pressure 
stabilised. 
Intraoperative fluctuations of blood pressure were 
present in 11 patients who underwent preoperative 
treatment with a-blockers and in two patients without 
this pre-treatment.
A sudden drop in blood pressure was observed 
in three patients after removal of the paraganglioma, 
which was managed with high doses of amines. All of 
these patients had preoperatively received a-blockers 
at a dose of 12 mg per day.
 The mean stay in hospital was six days, irrespec-
tive of surgical method. There were no cases of local 
or organ complications postoperatively. During the 
early postoperative period, normalisation of blood 
pressure was observed in 10 (76.9%) of the 12 patients 
with hypertension.  In those cases, continuation of 
hypotensive therapy was not needed. A similar situ-
ation was noted in the group of 10 patients with type 
2 diabetes. Normoglycaemia was achieved in eight 
patients (80%) postoperatively, allowing for cessation 
of hypoglycaemic agents.
The types of lesions found in histopathological 
studies of surgical specimens are presented in Table II. 
Discussion
The frequency of paragangliomas in the general popula-
tion is estimated to be 1–8 new cases per one million. 
They are most commonly located in the central nervous 
system. Another 21% of paragangliomas are located 
within the abdominal cavity. In this location they mainly 
present in ganglions of the sympathetic nervous system 
[1, 3], most often in the sympathetic trunk at the lateral 
surface of the vertebral column. Other, more infrequent 
sites involve the neck, chest, and urinary bladder.
When growing expansively, they may appear 
between the inferior vena cava and aorta, bilaterally 
below the renal vessels, and at the anterior aspect of 
the aortic wall between the inferior mesenteric artery 
and aortic bifurcation (organ of Zuckerkandl) [4]. Dis-
ease presentation in our study reflected this tendency. 
Paragangliomas located in proximity to the adrenal 
glands pose a clinical problem, especially when they are 
located between the vertebral column and adrenals. In 
six cases the authors were forced to perform adrenal-
ectomy together with ganglion resection. Right-sided 
removal of the paraganglioma usually involved ligation 
of the adrenal vein, which in turn led to unavoidable 
adrenalectomy. On the left side, direct contact between 
the paraganglioma and adrenal gland made separation 
of these structures impossible. 
In over 50% of cases, diagnosis of paraganglioma 
is related to a thorough work-up of paroxysmal hy-
pertension. The remaining cases are usually found 
by chance due to imaging of other abdominal organs 
(incidentaloma). More infrequently, clinical indications 
such as abdominal pain or palpable abdominal mass [4, 
5] lead to specific diagnostic imaging and discovery of 
paraganglioma. In the presented material paroxysmal 
hypertension was found in 46.4% of patients. Labora-
tory tests performed during patients’ hospitalisation in 
internal medicine or endocrine departments led to the 
diagnosis in all cases. Additionally, four of our patients 
(14.3%) had mutations in the RET gene. Other authors 
reported genetic mutations in paragangliomas in seven 
(26.7%) cases.
Surgical treatment of paragangliomas is indicated in 
all cases because even long-term asymptomatic surveil-
lance may be misleading. Additionally, catecholamine 
overproduction may cause sudden and dangerous 
elevations in blood pressure. Catecholamine release 
into the bloodstream may be triggered by any stressful 
situation. Currently laparoscopy, by both trans- and 
retroperitoneal access [6–8], is the surgical treatment 
of choice. This is feasible only in cases where paragan-
gliomas are located: along with sympathetic ganglions 
inferiorly to the renal vessels, in proximity to the renal 
hilum, and in some cases originating from the organ of 
Table II. The types of lesions found in histopathological 
studies of surgical specimens
Pathological results Number of patients 
Percentage 
(%)
Paraganglioma* 22 78.6
Ganglioneuroma 4 14.3
Schwannoma 2 7.1
Overall 28 100.0
*In two patients, there were three paragangliomas resected from the anterior 
wall of the aorta and left lateral surface of the vertebral column.  
Another two patients had a history of recurring paragangliomas after previous 
abdominal surgery. Present long-term follow-up includes 23 (82.1%) patients.  
The remaining five patients were lost to follow-up.
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Zuckerkandl. In the authors’ experience, paraganglio-
mas adjacent to the inferior vena cava and aorta, espe-
cially at the level of renal vessels and below, are not pos-
sible to be removed via laparoscopic approach. Tumours 
located at the level of the pancreas or diaphragmatic 
crura may result in serious difficulties even in open 
surgery. Because they are well-vascularised structures 
(aortic inflow and inferior vena caval outflow), their 
excision, especially at these locations, may result in 
dramatic intraoperational haemorrhage. Their vessels 
are usually short, and bleeding may be stopped only 
after underpinning the wall of the aorta or inferior vena 
cava, which is extremely difficult during laparoscopic 
approach. The authors qualified 11 (39.3%) patients for 
surgery by primary laparoscopic technique, while the 
remaining 17 (60.7%) were operated via open access 
due to inaccessible tumour location. 
In our material, the post-surgical histopathologi-
cal reports confirmed paragangliomas in 22 (78.6%) 
patients.  The remaining six cases (21.4%) proved to be 
other lesions (four ganglioneuroma; two schwannoma). 
Similar results were obtained by different authors [7]. 
In six patients the location of the lesion was within the 
organ of Zuckerkandl. This site is connected with high 
metastatic risk in up to 66% [9] of cases. Taking into 
consideration these data and the malignant potential 
of paragangliomas, which is estimated to be between 
10 and 35%, all patients with paragangliomas require 
strict follow-up during the postoperative period [10]. 
Conclusions
Laparoscopy can be feasible and safe in the treatment 
of paragangliomas, depending on the location of the 
tumour. The authors believe that tumours located be-
tween the inferior vena cava and aorta, especially at the 
level of the renal vessels and extending superiorly to the 
diaphragm, should be considered as a contraindication 
to laparoscopic access.
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